Literature DB >> 35913675

Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.

Francesco Prete1, MariaTeresa Rotelli2, Alessandro Stella3, Giovanna Calculli4, Lucia Ilaria Sgaramella4, Antonio Amati5, Nicoletta Resta3, Mario Testini4, Angela Gurrado4.   

Abstract

Sporadic intra-abdominal desmoid tumors are rare and known to potentially occur after trauma including previous surgery, although knowledge of the underlying pathogenetic mechanism is still limited. We reviewed the recent literature on sporadic intraabdominal desmoids and inflammation as we investigated the mutational and epigenetic makeup of a case of multiple synchronous mesenterial desmoids occurring after necrotizing pancreatitis. A 62-year-old man had four mesenteric masses up to 4.8 cm diameter detected on CT eighteen months after laparotomy for peripancreatic collections from necrotizing pancreatitis. All tumors were excised and diagnosed as mesenteric desmoids. DNA from peripheral blood was tested for a multigene panel. The tumour DNA was screened for three most frequent β-catenin gene mutations T41A, S45F and S45P. Expression levels of miR-21-3p and miR-197-3-p were compared between the desmoid tumors and other wild-type sporadic desmoids. The T41A CTNNB1 mutation was present in all four desmoid tumors. miR-21-3p and miR-197-3p were respectively upregulated and down-regulated in the mutated sporadic mesenteric desmoids, with respect to wild-type lesions. The patient is free from recurrence 34 months post-surgery. The literature review did not show similar studies. To our knowledge, this is the first study to interrogate genetic and epigenetic signature of multiple intraabdominal desmoids to investigate potential association with abdominal inflammation following surgery for necrotizing pancreatitis. We found mutational and epigenetic features that hint at potential activation of inflammation pathways within the desmoid tumor.
© 2022. The Author(s).

Entities:  

Keywords:  Beta catenin; Desmoid tumor; Inflammation; Mutation; Pancreatitis; microRNA

Year:  2022        PMID: 35913675     DOI: 10.1007/s10238-022-00849-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   5.057


  65 in total

1.  Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival.

Authors:  Sébastien Salas; Celine Brulard; Philippe Terrier; Dominique Ranchere-Vince; Agnes Neuville; Louis Guillou; Marick Lae; Agnes Leroux; Olivier Verola; Kurtz Jean-Emmanuel; Sylvie Bonvalot; Jean-Yves Blay; Axel Le Cesne; Alain Aurias; Jean-Michel Coindre; Frederic Chibon
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

2.  Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance.

Authors:  Winan J van Houdt; Olga Husson; Alisha Patel; Robin L Jones; Myles J F Smith; Aisha B Miah; Christina Messiou; Eleonor Moskovic; Omar Al-Muderis; Charlotte Benson; Shane Zaidi; Alison Dunlop; Dirk C Strauss; Andrew J Hayes; Winette T A van der Graaf
Journal:  Ann Surg Oncol       Date:  2019-09-17       Impact factor: 5.344

3.  Multifocal desmoids.

Authors:  Y Fong; P P Rosen; M F Brennan
Journal:  Surgery       Date:  1993-11       Impact factor: 3.982

4.  Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.

Authors:  B Kasper; C Baumgarten; S Bonvalot; R Haas; F Haller; P Hohenberger; G Moreau; W T A van der Graaf; A Gronchi
Journal:  Eur J Cancer       Date:  2014-11-27       Impact factor: 9.162

5.  Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.

Authors:  A Gronchi; C Colombo; C Le Péchoux; A P Dei Tos; A Le Cesne; A Marrari; N Penel; G Grignani; J Y Blay; P G Casali; E Stoeckle; F Gherlinzoni; P Meeus; C Mussi; F Gouin; F Duffaud; M Fiore; S Bonvalot
Journal:  Ann Oncol       Date:  2013-12-09       Impact factor: 32.976

6.  A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.

Authors:  Aimeé M Crago; Brian Denton; Sébastien Salas; Armelle Dufresne; James J Mezhir; Meera Hameed; Mithat Gonen; Samuel Singer; Murray F Brennan
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

Review 7.  Desmoid tumors: need for an individualized approach.

Authors:  Eelco de Bree; Ronald Keus; John Melissas; Dimitris Tsiftsis; Frits van Coevorden
Journal:  Expert Rev Anticancer Ther       Date:  2009-04       Impact factor: 4.512

8.  Desmoid tumors in patients with familial adenomatous polyposis.

Authors:  M A Rodriguez-Bigas; M C Mahoney; C P Karakousis; N J Petrelli
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

9.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions.

Authors:  Ioannis S Vlachos; Maria D Paraskevopoulou; Dimitra Karagkouni; Georgios Georgakilas; Thanasis Vergoulis; Ilias Kanellos; Ioannis-Laertis Anastasopoulos; Sofia Maniou; Konstantina Karathanou; Despina Kalfakakou; Athanasios Fevgas; Theodore Dalamagas; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2014-11-21       Impact factor: 16.971

Review 10.  Adult desmoid tumors: biology, management and ongoing trials.

Authors:  Nicolas Penel; Frédéric Chibon; Sébastien Salas
Journal:  Curr Opin Oncol       Date:  2017-07       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.